First of new generation of cancer drugs granted European approval

18 Dec 2014

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has today become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Read More

Skeletons in the cupboard of medical science

13 Feb 2014

In a talk on 17 February, Margaret Carlyle, a researcher in the Department of History and Philosophy of Science, will explore the fascinating (often gruesome) development in 18th-century Paris of anatomical models and introduce her audience to a remarkable woman who made her name in a field dominated by men.

Read More

Pages